456 related articles for article (PubMed ID: 12218568)
21. Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.
Uzan C; Kane A; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
Oncologist; 2011; 16(2):189-96. PubMed ID: 21273510
[TBL] [Abstract][Full Text] [Related]
22. Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary: a clinicopathologic analysis of 135 cases.
Smith Sehdev AE; Sehdev PS; Kurman RJ
Am J Surg Pathol; 2003 Jun; 27(6):725-36. PubMed ID: 12766576
[TBL] [Abstract][Full Text] [Related]
23. Early recurrence of ovarian serous borderline tumor as high-grade carcinoma: a report of two cases.
Parker RL; Clement PB; Chercover DJ; Sornarajah T; Gilks CB
Int J Gynecol Pathol; 2004 Jul; 23(3):265-72. PubMed ID: 15213603
[TBL] [Abstract][Full Text] [Related]
24. MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation.
Nakai G; Yamada T; Yamamoto K; Hirose Y; Ohmichi M; Narumi Y
J Ovarian Res; 2018 Jan; 11(1):7. PubMed ID: 29321056
[TBL] [Abstract][Full Text] [Related]
25. Advanced-stage serous borderline tumors of the ovary: a clinicopathological study of 49 cases.
Gilks CB; Alkushi A; Yue JJ; Lanvin D; Ehlen TG; Miller DM
Int J Gynecol Pathol; 2003 Jan; 22(1):29-36. PubMed ID: 12496695
[TBL] [Abstract][Full Text] [Related]
26. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
McKenney JK; Balzer BL; Longacre TA
Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
[TBL] [Abstract][Full Text] [Related]
27. Serous borderline tumor with micropapillary pattern of the right ovary that developed 6 recurrences over 30 years after primary surgery.
Minagawa M; Maeda M; Shimauchi M; Kishi H; Teshima S
Gynecol Oncol Rep; 2018 Aug; 25():45-47. PubMed ID: 30023420
[TBL] [Abstract][Full Text] [Related]
28. Ovarian micropapillary serous borderline tumors. Clinicopathologic features and outcome of seven surgically staged patients.
Goldstein NS; Ceniza N
Am J Clin Pathol; 2000 Sep; 114(3):380-6. PubMed ID: 10989638
[TBL] [Abstract][Full Text] [Related]
29. A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinoma.
Hannibal CG; Vang R; Junge J; Frederiksen K; Kurman RJ; Kjaer SK
Gynecol Oncol; 2017 Jan; 144(1):174-180. PubMed ID: 27836204
[TBL] [Abstract][Full Text] [Related]
30. Micropapillary serous carcinoma of the ovary: case report and review of literature.
Piura B; Rabinovich A; Yanai-Inbar I
Eur J Gynaecol Oncol; 2000; 21(4):374-6. PubMed ID: 11055486
[TBL] [Abstract][Full Text] [Related]
31. Results after conservative treatment of serous borderline tumours of the ovary with stromal microinvasion but without micropapillary pattern.
Laurent I; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
BJOG; 2009 May; 116(6):860-2. PubMed ID: 19432576
[TBL] [Abstract][Full Text] [Related]
32. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
[TBL] [Abstract][Full Text] [Related]
33. A clinicopathologic analysis of atypical proliferative (borderline) tumors and well-differentiated endometrioid adenocarcinomas of the ovary.
Bell KA; Kurman RJ
Am J Surg Pathol; 2000 Nov; 24(11):1465-79. PubMed ID: 11075848
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic difficulties in serous "borderline" tumors of the ovary].
Vereczkey I; Tóth E; Orosz Z
Magy Onkol; 2009 Mar; 53(1):23-31. PubMed ID: 19318323
[TBL] [Abstract][Full Text] [Related]
36. Assessing the landscape of ovarian serous borderline tumors.
Messini I; Doulgeraki T; Chrysanthakis D; Yiannou P; Gavresea T; Papadimitriou C; Panoskaltsis T; Voulgaris Z; Vlachos A; Pavlakis K
Int J Gynecol Cancer; 2019 Mar; 29(3):572-578. PubMed ID: 30659030
[TBL] [Abstract][Full Text] [Related]
37. Bilateral micropapillary serous carcinoma of the ovary: a case report.
Gupta R; Singh S; Nigam S
Arch Gynecol Obstet; 2007 May; 275(5):401-4. PubMed ID: 17031658
[TBL] [Abstract][Full Text] [Related]
38. Ovarian Low-grade Serous Carcinoma: A Clinicopathologic Study of 33 Cases With Primary Surgery Performed at a Single Institution.
Okoye E; Euscher ED; Malpica A
Am J Surg Pathol; 2016 May; 40(5):627-35. PubMed ID: 26900814
[TBL] [Abstract][Full Text] [Related]
39. Micropapillary pattern in serous borderline ovarian tumors: does it matter?
Park JY; Kim DY; Kim JH; Kim YM; Kim KR; Kim YT; Nam JH
Gynecol Oncol; 2011 Dec; 123(3):511-6. PubMed ID: 21917305
[TBL] [Abstract][Full Text] [Related]
40. Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.
Kubo C; Nagata S; Fukuda T; Kano R; Tanaka T; Nakanishi K; Ohsawa M; Nakatsuka SI
Diagn Pathol; 2018 Jun; 13(1):43. PubMed ID: 29960592
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]